Ophthalmology Times 2024 wrap-up: A year of innovation and insight
A look at the biggest news and advancements in ophthalmology in 2024.
A look at the biggest news and advancements in ophthalmology in 2024.
Investigators conducted a retrospective clinical audit to determine why patients do not adhere to the guidelines among about 9,000 patients in a practice.
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.
No signs of tissue rejection, phthisis, or sympathetic ophthalmia have been seen in the recipient of the first complete eye and partial face transplant, though…
Jason Bacharach, MD, joins host I. Paul Singh, MD, to discuss a study exploring patient-reported outcomes after switching to or starting a preservative-free latanoprost formulation.…
Geographic atrophy (GA), an advanced, progressive form of dry age-related macular degeneration, affects approximately 5 million people worldwide, and results in significant visual function decline.1,2…
With an evolving understanding and new discoveries in extracellular vesicle (EV) biology and their implications in health and disease, the significant diagnostic and therapeutic potential…
Research to Prevent Blindness has opened applications for four IRIS Registry research grants. The deadline to apply is Jan. 31.
To compare the outcomes of intravitreal melphalan (IVit-M) versus intravitreal topotecan (IVit-T) for vitreous seeds (VS) in retinoblastoma (RB).
Purpose To assess real-time intraoperative pachymetry changes occurring during corneal cross-linking (CXL) using microscope-integrated optical coherence tomography (Mi-OCT) and compare accuracy of various modalities of…
Wills Eye Resident Series : A patient presents with decreased vision after an injury , p. 62 medicare Q & A 2024 Reimbursement Update Wills…